{
    "organizations": [],
    "uuid": "43a51cf4eceeb189fb0997a86e913655f4d83164",
    "author": "",
    "url": "https://www.reuters.com/article/brief-inspiremd-announces-commercial-lau/brief-inspiremd-announces-commercial-launch-and-first-sales-of-cguard-eps-in-india-idUSFWN1QA0LA",
    "ord_in_thread": 0,
    "title": "BRIEF-Inspiremd Announces Commercial Launch And First Sales Of Cguard™ EPS In India",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "February 20, 2018 / 2:58 PM / Updated 5 minutes ago BRIEF-Inspiremd Announces Commercial Launch And First Sales Of Cguard™ EPS In India Reuters Staff Feb 20 (Reuters) - Inspiremd Inc: * INSPIREMD ANNOUNCES COMMERCIAL LAUNCH AND FIRST SALES OF CGUARD™ EPS IN INDIA * INSPIREMD INC - ‍ANNOUNCED COMMERCIAL LAUNCH AND FIRST SALES OF CGUARD EMBOLIC PREVENTION SYSTEM IN INDIA​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)",
    "published": "2018-02-20T16:55:00.000+02:00",
    "crawled": "2018-02-20T17:15:38.008+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "february",
        "pm",
        "updated",
        "minute",
        "ago",
        "announces",
        "commercial",
        "launch",
        "first",
        "sale",
        "eps",
        "india",
        "reuters",
        "staff",
        "feb",
        "reuters",
        "inspiremd",
        "inc",
        "inspiremd",
        "announces",
        "commercial",
        "launch",
        "first",
        "sale",
        "eps",
        "india",
        "inspiremd",
        "inc",
        "commercial",
        "launch",
        "first",
        "sale",
        "cguard",
        "embolic",
        "prevention",
        "system",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}